vs

Side-by-side financial comparison of Amphenol (APH) and Corteva (CTVA). Click either name above to swap in a different company.

Amphenol is the larger business by last-quarter revenue ($7.6B vs $3.9B, roughly 1.9× Corteva). Amphenol runs the higher net margin — 12.4% vs -14.1%, a 26.5% gap on every dollar of revenue. On growth, Amphenol posted the faster year-over-year revenue change (58.4% vs -1.7%). Corteva produced more free cash flow last quarter ($4.2B vs $831.2M). Over the past eight quarters, Amphenol's revenue compounded faster (45.3% CAGR vs -6.7%).

Amphenol Corporation is an American producer of electronic and fiber optic connectors, cable and interconnect systems such as coaxial cables. Amphenol is a portmanteau from the corporation's original name, American Phenolic Corp.

Corteva, Inc. is an American company devoted to products for seeds and crop protection, including herbicides, insecticides, fungicides, and biologicals that are sold in 110 countries. The company's name combines "cor" with "teva". It is headquartered in Indianapolis, Indiana. Corteva sells a large portion of their seeds under the Pioneer Hi-Bred International brand.

APH vs CTVA — Head-to-Head

Bigger by revenue
APH
APH
1.9× larger
APH
$7.6B
$3.9B
CTVA
Growing faster (revenue YoY)
APH
APH
+60.1% gap
APH
58.4%
-1.7%
CTVA
Higher net margin
APH
APH
26.5% more per $
APH
12.4%
-14.1%
CTVA
More free cash flow
CTVA
CTVA
$3.3B more FCF
CTVA
$4.2B
$831.2M
APH
Faster 2-yr revenue CAGR
APH
APH
Annualised
APH
45.3%
-6.7%
CTVA

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
APH
APH
CTVA
CTVA
Revenue
$7.6B
$3.9B
Net Profit
$943.3M
$-552.0M
Gross Margin
36.7%
42.4%
Operating Margin
24.0%
-13.6%
Net Margin
12.4%
-14.1%
Revenue YoY
58.4%
-1.7%
Net Profit YoY
26.8%
-1246.3%
EPS (diluted)
$0.72
$-0.80

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APH
APH
CTVA
CTVA
Q1 26
$7.6B
Q4 25
$6.4B
$3.9B
Q3 25
$6.2B
$2.6B
Q2 25
$5.7B
$6.5B
Q1 25
$4.8B
$4.4B
Q4 24
$4.3B
$4.0B
Q3 24
$4.0B
$2.3B
Q2 24
$3.6B
$6.1B
Net Profit
APH
APH
CTVA
CTVA
Q1 26
$943.3M
Q4 25
$1.2B
$-552.0M
Q3 25
$1.2B
$-320.0M
Q2 25
$1.1B
$1.3B
Q1 25
$737.8M
$652.0M
Q4 24
$746.1M
$-41.0M
Q3 24
$604.4M
$-524.0M
Q2 24
$524.8M
$1.1B
Gross Margin
APH
APH
CTVA
CTVA
Q1 26
36.7%
Q4 25
38.2%
42.4%
Q3 25
38.1%
37.2%
Q2 25
36.3%
54.6%
Q1 25
34.2%
47.0%
Q4 24
34.3%
37.3%
Q3 24
33.6%
32.7%
Q2 24
33.6%
52.3%
Operating Margin
APH
APH
CTVA
CTVA
Q1 26
24.0%
Q4 25
26.8%
-13.6%
Q3 25
27.5%
-14.1%
Q2 25
25.1%
27.9%
Q1 25
21.3%
17.7%
Q4 24
22.1%
2.2%
Q3 24
20.3%
-27.2%
Q2 24
19.4%
21.9%
Net Margin
APH
APH
CTVA
CTVA
Q1 26
12.4%
Q4 25
18.6%
-14.1%
Q3 25
20.1%
-12.2%
Q2 25
19.3%
20.4%
Q1 25
15.3%
14.8%
Q4 24
17.3%
-1.0%
Q3 24
15.0%
-22.5%
Q2 24
14.5%
17.2%
EPS (diluted)
APH
APH
CTVA
CTVA
Q1 26
$0.72
Q4 25
$0.93
$-0.80
Q3 25
$0.97
$-0.47
Q2 25
$0.86
$1.92
Q1 25
$0.58
$0.95
Q4 24
$0.16
$-0.05
Q3 24
$0.48
$-0.76
Q2 24
$0.41
$1.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APH
APH
CTVA
CTVA
Cash + ST InvestmentsLiquidity on hand
$4.6B
$4.5B
Total DebtLower is stronger
$18.7B
$1.7B
Stockholders' EquityBook value
$14.1B
$24.1B
Total Assets
$42.1B
$42.8B
Debt / EquityLower = less leverage
1.33×
0.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APH
APH
CTVA
CTVA
Q1 26
$4.6B
Q4 25
$11.4B
$4.5B
Q3 25
$3.9B
$2.6B
Q2 25
$3.2B
$2.1B
Q1 25
$1.7B
$2.0B
Q4 24
$3.3B
$3.2B
Q3 24
$1.6B
$2.5B
Q2 24
$1.3B
$2.0B
Total Debt
APH
APH
CTVA
CTVA
Q1 26
$18.7B
Q4 25
$14.6B
$1.7B
Q3 25
$7.1B
$1.7B
Q2 25
$7.1B
$1.7B
Q1 25
$6.8B
$1.8B
Q4 24
$6.5B
$2.0B
Q3 24
$5.1B
$2.0B
Q2 24
$5.0B
$2.5B
Stockholders' Equity
APH
APH
CTVA
CTVA
Q1 26
$14.1B
Q4 25
$13.4B
$24.1B
Q3 25
$12.5B
$25.2B
Q2 25
$11.5B
$25.9B
Q1 25
$10.3B
$24.3B
Q4 24
$9.8B
$23.8B
Q3 24
$9.5B
$24.7B
Q2 24
$9.0B
$25.2B
Total Assets
APH
APH
CTVA
CTVA
Q1 26
$42.1B
Q4 25
$36.2B
$42.8B
Q3 25
$27.1B
$42.2B
Q2 25
$25.7B
$41.8B
Q1 25
$22.9B
$42.1B
Q4 24
$21.4B
$40.8B
Q3 24
$19.6B
$41.9B
Q2 24
$18.6B
$41.5B
Debt / Equity
APH
APH
CTVA
CTVA
Q1 26
1.33×
Q4 25
1.09×
0.07×
Q3 25
0.57×
0.07×
Q2 25
0.62×
0.07×
Q1 25
0.66×
0.07×
Q4 24
0.66×
0.08×
Q3 24
0.54×
0.08×
Q2 24
0.56×
0.10×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APH
APH
CTVA
CTVA
Operating Cash FlowLast quarter
$1.1B
$4.4B
Free Cash FlowOCF − Capex
$831.2M
$4.2B
FCF MarginFCF / Revenue
10.9%
106.2%
Capex IntensityCapex / Revenue
3.8%
5.7%
Cash ConversionOCF / Net Profit
1.19×
TTM Free Cash FlowTrailing 4 quarters
$4.6B
$2.8B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APH
APH
CTVA
CTVA
Q1 26
$1.1B
Q4 25
$1.7B
$4.4B
Q3 25
$1.5B
$193.0M
Q2 25
$1.4B
$947.0M
Q1 25
$764.9M
$-2.1B
Q4 24
$847.1M
$4.2B
Q3 24
$704.0M
$130.0M
Q2 24
$664.1M
$451.0M
Free Cash Flow
APH
APH
CTVA
CTVA
Q1 26
$831.2M
Q4 25
$1.5B
$4.2B
Q3 25
$1.2B
$36.0M
Q2 25
$1.1B
$829.0M
Q1 25
$576.3M
$-2.2B
Q4 24
$647.3M
$4.0B
Q3 24
$474.0M
$-24.0M
Q2 24
$522.8M
$337.0M
FCF Margin
APH
APH
CTVA
CTVA
Q1 26
10.9%
Q4 25
22.8%
106.2%
Q3 25
19.6%
1.4%
Q2 25
19.8%
12.8%
Q1 25
12.0%
-49.9%
Q4 24
15.0%
100.4%
Q3 24
11.7%
-1.0%
Q2 24
14.5%
5.5%
Capex Intensity
APH
APH
CTVA
CTVA
Q1 26
3.8%
Q4 25
3.9%
5.7%
Q3 25
4.2%
6.0%
Q2 25
5.3%
1.8%
Q1 25
3.9%
2.1%
Q4 24
4.6%
4.6%
Q3 24
5.7%
6.6%
Q2 24
3.9%
1.9%
Cash Conversion
APH
APH
CTVA
CTVA
Q1 26
1.19×
Q4 25
1.44×
Q3 25
1.18×
Q2 25
1.30×
0.72×
Q1 25
1.04×
-3.23×
Q4 24
1.14×
Q3 24
1.16×
Q2 24
1.27×
0.43×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

APH
APH

Communications Solutions$4.5B60%
Harsh Environment Solutions$1.7B22%
Interconnect and Sensor Systems$1.4B18%

CTVA
CTVA

Corn$1.4B35%
Herbicides$1.1B27%
Insecticides$488.0M12%
Fungicides$272.0M7%
Biologicals$191.0M5%
Soybean$164.0M4%
Other$160.0M4%
Otheroilseeds$94.0M2%

Related Comparisons